101 related articles for article (PubMed ID: 2821756)
1. Anaphylactic release of platelet activating factor acether and eicosanoids from lungs of guinea pigs sensitized to ovalbumin aerosol.
Parente L; Fitzgerald MF; Moncada S
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():171-6. PubMed ID: 2821756
[No Abstract] [Full Text] [Related]
2. Inhibition of the release of prostaglandins, thromboxanes, and leukotrienes from anaphylactic lungs by a platelet-activating factor (PAF) antagonist and its stimulation by PAF.
Sirois P; Harczy M; Braquet P; Borgeat P; Maclouf J; Pradelles P
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1033-7. PubMed ID: 2823554
[No Abstract] [Full Text] [Related]
3. Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection.
Pretolani M; Lefort J; Vargaftig BB
Am Rev Respir Dis; 1988 Dec; 138(6):1572-8. PubMed ID: 3202509
[TBL] [Abstract][Full Text] [Related]
4. Adenosine and eicosanoid release from immunologically challenged human lung fragments.
Viganò T; Toia A; Galli G; Berti F; Crivellari MT; Mezzetti M; Folco GC
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():992-6. PubMed ID: 2823581
[No Abstract] [Full Text] [Related]
5. Release of leukotrienes and histamine by the isolated anaphylactic heart.
Salari H; Pelletier G
Immunopharmacol Immunotoxicol; 1987; 9(2-3):217-34. PubMed ID: 2449485
[TBL] [Abstract][Full Text] [Related]
6. Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether.
Detsouli A; Lefort J; Vargaftig BB
Br J Pharmacol; 1985 Apr; 84(4):801-10. PubMed ID: 4005486
[TBL] [Abstract][Full Text] [Related]
7. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig.
Lagente V; Touvay C; Randon J; Desquand S; Cirino M; Vilain B; Lefort J; Braquet P; Vargaftig BB
Prostaglandins; 1987 Feb; 33(2):265-74. PubMed ID: 2438723
[TBL] [Abstract][Full Text] [Related]
8. Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstriction.
Vargaftig BB
Agents Actions Suppl; 1983; 13():155-71. PubMed ID: 6575594
[TBL] [Abstract][Full Text] [Related]
9. Interference of the PAF-acether antagonist BN 52021 with anaphylaxis in the guinea pig.
Desquand S; Vilain B; Lagente V; Randon J; Touvay C; Lefort J; Braquet P; Vargaftig BB
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():818-21. PubMed ID: 2445183
[No Abstract] [Full Text] [Related]
10. Effect of vasoactive intestinal peptide and calcitonin gene-related peptide on leukotriene release from guinea pig and rat lung.
Tippins JR; Di Marzo V; Morris HR
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1028-32. PubMed ID: 2823553
[No Abstract] [Full Text] [Related]
11. Enhancement of plasma levels of biologically active leukotriene B compounds during anaphylaxis in guinea pigs pretreated by indomethacin or by a fish oil-enriched diet.
Lee TH; Israel E; Drazen JM; Leitch AG; Ravalese J; Corey EJ; Robinson DR; Lewis RA; Austen KF
J Immunol; 1986 Apr; 136(7):2575-82. PubMed ID: 3005414
[TBL] [Abstract][Full Text] [Related]
12. A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction.
Cirino M; Lagente V; Lefort J; Vargaftig BB
Prostaglandins; 1986 Jul; 32(1):121-6. PubMed ID: 3763941
[TBL] [Abstract][Full Text] [Related]
13. The PAF-acether receptor antagonist BN-52021 inhibits mediator release during guinea-pig active lung anaphylaxis.
Berti F; Galli G; Magni F; Rossoni G; Villa L; Puglisi L; Pasargiklian R; Braquet P
Pharmacol Res Commun; 1988 Dec; 20(12):1047-59. PubMed ID: 2463644
[TBL] [Abstract][Full Text] [Related]
14. Relevance of mediators to cardiac parameters of isolated anaphylactic guinea-pig heart.
Mest HJ; Pönicke K; Heinroth-Hoffmann I; Meissner N; Giessler C
Prostaglandins Leukot Essent Fatty Acids; 1995 Jul; 53(1):21-9. PubMed ID: 7545818
[TBL] [Abstract][Full Text] [Related]
15. The booster injection of antigen during active sensitization of guinea-pig modifies the anti-anaphylactic activity of the PAF antagonist WEB 2086.
Desquand S; Lefort J; Dumarey C; Vargaftig BB
Br J Pharmacol; 1990 Jun; 100(2):217-22. PubMed ID: 2379029
[TBL] [Abstract][Full Text] [Related]
16. Use of steroidal antiinflammatory drug provides further evidence for a potential role of PAF-acether in bronchial anaphylaxis.
Chignard M; Le Còuedic JP; Andersson P; Brange C
Int Arch Allergy Appl Immunol; 1986; 81(2):184-5. PubMed ID: 3759260
[TBL] [Abstract][Full Text] [Related]
17. The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs.
Fitzgerald MF; Moncada S; Parente L
Br J Pharmacol; 1986 May; 88(1):149-53. PubMed ID: 3708213
[TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid metabolism and SRS-A.
Piper PJ; Tippins JR; Morris HR; Taylor GW
Agents Actions Suppl; 1979; (4):37-48. PubMed ID: 115260
[No Abstract] [Full Text] [Related]
19. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor and the cardiovascular system: involvement in cardiac anaphylaxis.
Stewart AG; Piper PJ
Prog Biochem Pharmacol; 1988; 22():132-40. PubMed ID: 3136455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
